On Monday, federal health officials showcased commitments from the health insurance sector aimed at simplifying and reforming the pre-authorization process for Medicare Advantage.
Robert F. Kennedy Jr., the Director General of Health and Human Services (HHS), and Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, held a roundtable with insurance executives who promised to implement six key reforms to the pre-authorization procedure.
Healthcare providers have long criticized the requirement to obtain insurer approval for certain services, citing delays and complications in care delivery.
Oz mentioned that the roundtable included CEOs from major insurance companies that collectively cover around 75% of the U.S. population. CMS officials indicated that they aimed to reduce the number of services that would need pre-approval.
Examples provided by Medicare director Chris Cromp included colonoscopy and cataract surgery as potential candidates for removal from the pre-approval protocol.
In a press briefing, Oz referred to a biblical adage about meekness, suggesting that both healthcare providers and insurers have agreed to adopt a more humble approach during this reform period.
Large insurance providers such as Cigna, UnitedHealthcare, and Aetna are actively working to simplify and cut down on the number of claims that require prior approval. Their commitments include standardizing electronic pre-certification processes, ensuring smooth transitions for patients changing plans, and improving overall communication regarding decision-making.
Oz estimated that these changes could save “tens of millions of dollars” by reducing wastage.
Kennedy acknowledged that the insurance sector has made similar commitments in the past, but emphasized that this situation is unique due to the number of insurers involved and the presence of concrete standards and metrics for success.
Oz pointed out a shift in the public sentiment towards pre-approval processes, noting that there is significant frustration around these issues that can lead to serious public outcry.
He emphasized that the healthcare landscape is fragmented and often hampered by outdated methods, which can cause dissatisfaction among patients and providers alike. The goal, he said, is to create a more seamless patient experience while allowing healthcare providers to concentrate on delivering quality care.
The American Medical Association’s 2024 Survey revealed that 91% of doctors believe pre-authorization can lead to negative clinical results, with 82% noting that it may cause patients to abandon necessary treatments.
Oz acknowledged that while the commitments made are voluntary, there could be governmental intervention if the insurance industry fails to address pre-approval necessities efficiently, suggesting that such intervention could prompt more rapid changes.
Actor Eric Dane, known for his role in “Grey’s Anatomy,” who has shared his battle with ALS, also participated in a press conference to lend his support. He communicated the uncertainties that come with illness and criticized unnecessary pre-authorization hurdles that can further complicate patients’ lives.
Senators Roger Marshall (R-Kan.) and Greg Murphy (R-N.C.) joined Kennedy and Oz at HHS headquarters, both having previously introduced proposals aimed at reforming the pre-approval process in Medicare.
They shared personal stories illustrating how the pre-approval system negatively impacts patient care. Marshall recounted a case of a patient whose scheduled surgery was delayed at the last minute due to extra steps required by the insurance company.
Though optimistic about the commitments made, Marshall expressed his determination to formalize pre-approval reforms into law.
Murphy, who identifies as a skeptic, stated he would be monitoring the insurers closely to ensure they follow through with their pledges. He also highlighted the potential role of artificial intelligence in transforming the pre-approval process.
However, he expressed caution, noting that the effectiveness of AI is dependent on the quality of input data, and raised concerns over evidence suggesting AI might lead to an increase in claim rejections.
This past March, Murphy reintroduced a bipartisan bill aimed at reducing unnecessary delays in healthcare, which would prevent contractors from denying claims purely on the basis of not meeting certain standards and require input from medical professionals in establishing clinical protocols for reviews.
